Shopping Cart
- Remove All
- Your shopping cart is currently empty
Anagrelide hydrochloride (BL4162A) serves as a treatment for essential thrombocytosis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $34 | In Stock | |
10 mg | $50 | In Stock | |
25 mg | $81 | In Stock | |
50 mg | $161 | In Stock | |
100 mg | $292 | In Stock | |
200 mg | $457 | In Stock |
Description | Anagrelide hydrochloride (BL4162A) serves as a treatment for essential thrombocytosis. |
In vitro | Anagrelide is an oral imidazoquinazoline agent with an anti-cyclic AMP phosphodiesterase activity and inhibits platelet aggregation in both humans and animals. Anagrelide works by inhibiting the maturation of platelets from megakaryocytes. |
Alias | BMY 26538-01, BL4162A, Anagrelide HCl, Agrylin |
Molecular Weight | 292.55 |
Formula | C10H7Cl2N3O·HCl |
Cas No. | 58579-51-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
Solubility Information | DMSO: 2.9 mg/mL (10 mM) | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.